The longer this corrupt SeroquelXR final approval delay goes the more important PAR launching the remaining 4 FocalinXR strengths becomes.
Almost a guarantee that the corrupt FDA generics divisions doesn't approve any other IPCI ANDA's by/b4 this September...despite all the empty promises over the past year that the FDA was supposedly mandated to clear out the entire ANDA backlog!